Replies to post #57459 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Please remember, the '113 trial will not be FULLY enrolled until Q3 2015, and we all know the FDA will insist that Ariad accomplish full enrollment due to Ariad's sordid past. THEN, Ariad HAS to file a NDA for approval. The FDA will take AT LEAST 6 months for review and possible early approval, so, the absolute earliest date for approval would be Q2 or Q3 2016. That is the facts..